FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Redston

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Mouse

Physiology

Genes & Molecular Sequences

APC Genes

Procedures

Immunohistochemistry

Co-author Network

Publications

TOP 3
Maria McIntire; Mark Redston
Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.
Nancy L Cho; Rian M Hasson; Mark Redston; Hira Rizvi; Adelaide M Carothers; Monica M Bertagnolli
Immunohistochemical and molecular analysis of tyrosine kinase activity in desmoid tumors.
Monica M Bertagnolli; Thomas A Colacchio; Carolyn Corlies Compton; Richard M Goldberg; Robert J Mayer; Donna Niedzwiecki; Mark Redston; Leonard B Saltz; Robert S Warren
Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Redston (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Maria McIntire; Mark Redston
Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.
Archives of pathology & laboratory medicine 2012;136(5):496-503.
2012: Nancy L Cho; Rian M Hasson; Mark Redston; Hira Rizvi; Adelaide M Carothers; Monica M Bertagnolli
Immunohistochemical and molecular analysis of tyrosine kinase activity in desmoid tumors.
The Journal of surgical research 2012;173(2):320-6.
2011: Monica M Bertagnolli; Thomas A Colacchio; Carolyn Corlies Compton; Richard M Goldberg; Robert J Mayer; Donna Niedzwiecki; Mark Redston; Leonard B Saltz; Robert S Warren
Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3153-62.
2009: Monica M Bertagnolli; Donna Niedzwiecki; Carolyn Corlies Compton; Hejin P Hahn; Margaret Hall; Beatrice Damas; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Robert S Warren; Mark Redston
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1814-21.
2009: Monica M Bertagnolli; Craig J Eagle; Ann G Zauber; Mark Redston; Aurora Breazna; KyungMann Kim; Jie Tang; Rebecca B Rosenstein; Asad Umar; Donya Bagheri; Neal T Collins; John Burn; Daniel C Chung; Thomas Dewar; T Raymond Foley; Neville Hoffman; Finlay Macrae; Ronald E Pruitt; John R Saltzman; Bruce Salzberg; Thomas Sylwestrowicz; Ernest T Hawk
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.
Cancer prevention research (Philadelphia, Pa.) 2009;2(4):310-21.
2009: Monica M Bertagnolli; Robert S Warren; Donna Niedzwiecki; Elke Mueller; Carolyn Corlies Compton; Mark Redston; Margaret Hall; Hejin P Hahn; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Massimo Loda
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2116-22.
2009: Jennifer A Sparr; Prathap Bandipalliam; Mark Redston; Sapna Syngal
Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome.
The American journal of surgical pathology 2009;33(2):309-12.
2009: Matthew H Kulke; Jason L Hornick; Christine Frauenhoffer; Susanne Hooshmand; David P Ryan; Peter C Enzinger; Jeffrey A Meyerhardt; jeffrey clark; Keith Stuart; Charles S Fuchs; Mark Redston
O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):338-45.
2008: Alec C Kimmelman; Aram F Hezel; Andrew J Aguirre; Hongwu Zheng; Ji-Hye Paik; Haoqiang Ying; Gerald Chu; Jean X Zhang; Ergun Sahin; Giminna Yeo; Aditya Ponugoti; Roustem Nabioullin; Scott Deroo; Shenghong Yang; Xiaoxu Wang; John P McGrath; Marina Protopopova; Elena Ivanova; Jianhua Zhang; Bin Feng; Ming Tsao; Mark Redston; Alexei Protopopov; Yonghong Xiao; P Andrew Futreal; William C Hahn; David S Klimstra; Lynda Chin; Ronald A DePinho
Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(49):19372-7.
2008: Lynn-Kristin Bracht; Patrick Y Wen; Jeffrey A Meyerhardt; Matthew H Kulke; Jason L Hornick; Mark Redston; Debra Conrad LaFrankie; Peter M Black; Santosh kesari; Andrew Norden; Jan Drappatz
DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4843-4.
2008: Sean P Cleary; H Kim; Marina E Croitoru; Mark Redston; Julia A Knight; Steven Gallinger; Robert Gryfe
Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk.
Diseases of the colon and rectum 2008;51(10):1467-73; discussion 1473-4.
2008: Siong-Seng Liau; Flavio Rocha; Evan Matros; Mark Redston; Edward E Whang
High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
Cancer 2008;113(2):302-14.
2008: Nancy L Cho; Mark Redston; Ann G Zauber; Adelaide M Carothers; Jason L Hornick; Andrew Wilton; Stephen Sontag; Norman Nishioka; Francis M Giardiello; John R Saltzman; Chris Gostout; Craig J Eagle; Ernest T Hawk; Monica M Bertagnolli
Aberrant crypt foci in the adenoma prevention with celecoxib trial.
Cancer prevention research (Philadelphia, Pa.) 2008;1(1):21-31.
2008: Rajenda S Singh; Wayne Grayson; Mark Redston; A Hafeez Diwan; Carla L Warneke; Phillip H McKee; Dina Lev; Stephen Lyle; Eduardo Calonje; Alexander Lazar
Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia.
The American journal of surgical pathology 2008;32(6):936-42.
2008: Amitabh Srivastava; Mark Redston; Francis A Farraye; Rhonda K Yantiss; Robert D Odze
Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity.
The American journal of surgical pathology 2008;32(2):296-303.
2007: Eric S Martin; Giovanni Tonon; Raktim Sinha; Yonghong Xiao; Bin Feng; Alec C Kimmelman; Alexei Protopopov; Elena Ivanova; Cameron Brennan; Kate Montgomery; Raju Kucherlapati; Gerald Bailey; Mark Redston; Lynda Chin; Ronald A DePinho
Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types.
Cancer research 2007;67(22):10736-43.
2007: Amitabh Srivastava; Robert D Odze; Gregory Y Lauwers; Mark Redston; Donald A Antonioli; Jonathan N Glickman
Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia.
The American journal of surgical pathology 2007;31(11):1733-41.
2007: Rhonda K Yantiss; Kirstine Y Oh; Yao-Tseng Chen; Mark Redston; Robert D Odze
Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases.
The American journal of surgical pathology 2007;31(8):1238-45.
2007: Mark A Jenkins; Shinichi Hayashi; Anne-Marie O'Shea; Lawrence J Burgart; Tom C Smyrk; David Shimizu; Paul M Waring; Andrew Ruszkiewicz; Aaron Pollett; Mark Redston; Melissa A Barker; John A Baron; Graham R Casey; James G Dowty; Graham G Giles; Paul Limburg; Polly Newcomb; Joanne P Young; Michael D Walsh; Stephen N Thibodeau; Noralane M Lindor; Loïc Lemarchand; Steven Gallinger; Robert W Haile; John D Potter; John L Hopper; Jeremy R Jass
Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.
Gastroenterology 2007;133(1):48-56.
2007: Nancy L Cho; Sara H Javid; Adelaide M Carothers; Mark Redston; Monica M Bertagnolli
Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice.
Cancer research 2007;67(5):2366-72.
2006: Monica M Bertagnolli; Craig J Eagle; Ann G Zauber; Mark Redston; Scott D Solomon; KyungMann Kim; Jie Tang; Rebecca B Rosenstein; Janet Wittes; Donald Corle; Timothy M Hess; G Mabel Woloj; Frédéric Boisserie; William F Anderson; Jaye L Viner; Donya Bagheri; John Burn; Daniel C Chung; Thomas Dewar; T Raymond Foley; Neville Hoffman; Finlay Macrae; Ronald E Pruitt; John R Saltzman; Bruce Salzberg; Thomas Sylwestrowicz; Gary B Gordon; Ernest T Hawk
Celecoxib for the prevention of sporadic colorectal adenomas.
The New England journal of medicine 2006;355(9):873-84.
2006: Adelaide M Carothers; Amy E Moran; Nancy L Cho; Mark Redston; Monica M Bertagnolli
Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor.
Cancer research 2006;66(12):6432-8.
2006: Nabeel Bardeesy; Andrew J Aguirre; Gerald Chu; Kuang-hung Cheng; Lyle V Lopez; Aram F Hezel; Bin Feng; Cameron Brennan; Ralph Weissleder; Umar Mahmood; Douglas Hanahan; Mark Redston; Lynda Chin; Ronald A DePinho
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(15):5947-52.
2006: Mark Redston; Carolyn Corlies Compton; Brent W Miedema; Donna Niedzwiecki; Jeannette M Dowell; Scott D Jewell; James M Fleshman; Jiri Bem; Robert J Mayer; Monica M Bertagnolli
Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):878-83.
2006: Adelaide M Carothers; Sara H Javid; Amy E Moran; Daniel H Hunt; Mark Redston; Monica M Bertagnolli
Deficient E-cadherin adhesion in C57BL/6J-Min/+ mice is associated with increased tyrosine kinase activity and RhoA-dependent actomyosin contractility.
Experimental cell research 2006;312(4):387-400.
2006: Evan Matros; Gerald Bailey; Thomas E Clancy; MICHAEL ZINNER; Stanley Ashley; Edward E Whang; Mark Redston
Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival.
Cancer 2006;106(3):693-702.
2006: Vikas K Goel; Alexander Lazar; Carla L Warneke; Mark Redston; Frank G Haluska
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.
The Journal of investigative dermatology 2006;126(1):154-60.
2006: Ralph Hruban; N Volkan Adsay; Jorge Albores-Saavedra; Miriam R Anver; Andrew V Biankin; Gregory P Boivin; Emma E Furth; Toru Furukawa; Alison P Klein; David S Klimstra; Gunter Kloppel; Gregory Y Lauwers; Daniel S Longnecker; Jutta Luttges; Anirban Maitra; G Johan A Offerhaus; Lucía Pérez-Gallego; Mark Redston; David A Tuveson
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
Cancer research 2006;66(1):95-106.
2005: Julinor Bacani; Rhonda Zwingerman; Nando Di Nicola; Samantha Spencer; Trish Wegrynowski; Kyle Mitchell; Kazy Hay; Mark Redston; Eric Holowaty; David Huntsman; Aaron Pollett; Robert H Riddell; Steven Gallinger
Tumor microsatellite instability in early onset gastric cancer.
The Journal of molecular diagnostics : JMD 2005;7(4):465-77.
2005: Mark Duxbury; Evan Matros; Thomas E Clancy; Gerald Bailey; Michael Doff; MICHAEL ZINNER; Stanley W Ashley; Anirban Maitra; Mark Redston; Edward E Whang
CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
Annals of surgery 2005;241(3):491-6.
2005: Henry D Haskell; Harley A Haynes; Phillip H McKee; Mark Redston; Scott R Granter; Alexander Lazar
Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin.
Journal of cutaneous pathology 2005;32(3):245-50.
2005: Sara H Javid; Amy E Moran; Adelaide M Carothers; Mark Redston; Monica M Bertagnolli
Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/+) mouse model of colorectal cancer.
Carcinogenesis 2005;26(3):587-95.
2005: Amy E Moran; Adelaide M Carothers; Michael J Weyant; Mark Redston; Monica M Bertagnolli
Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse.
Cancer research 2005;65(3):1097-104.
2005: Alexander Lazar; Eduardo Calonje; Wayne Grayson; Angelo P Dei Tos; Martin C Mihm; Mark Redston; Phillip H McKee
Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin.
Journal of cutaneous pathology 2005;32(2):148-57.
2005: Kirstine Oh; Mark Redston; Robert D Odze
Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon.
Human pathology 2005;36(1):101-11.
2005: Maina Lepourcelet; Liqiang Tou; Li Cai; Jun-ichi Sawada; Alexander Lazar; Jonathan N Glickman; Jessica A Williamson; Allen Everett; Mark Redston; Edward A Fox; Yoshihiro Nakatani; Ramesh A Shivdasani
Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).
Development (Cambridge, England) 2005;132(2):415-27.
2004: Marina E Croitoru; Sean P Cleary; Nando Di Nicola; Michael Manno; Teresa Selander; Melyssa Aronson; Mark Redston; Michelle Cotterchio; Julia Knight; Robert Gryfe; Steven Gallinger
Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk.
Journal of the National Cancer Institute 2004;96(21):1631-4.
2004: Riad Haddad; Robert T Ogilvie; Marina E Croitoru; Victoria Muniz; Robert Gryfe; Aaron Pollet; Preshanthini Shanmugathasan; Timothy L Fitzgerald; Calvin H L Law; Sherif S Hanna; Serge Jothy; Mark Redston; Steven Gallinger; Andrew J Smith
Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases.
Annals of surgical oncology 2004;11(11):977-82.
2004: Amy E Moran; Daniel H Hunt; Sara H Javid; Mark Redston; Adelaide M Carothers; Monica M Bertagnolli
Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.
The Journal of biological chemistry 2004;279(41):43261-72.
2004: Monica M Bertagnolli; Brent W Miedema; Mark Redston; Jeannette Dowell; Donna Niedzwiecki; James W Fleshman; Jiri Bem; Robert Mayer; MICHAEL ZINNER; Carolyn Corlies Compton
Sentinel node staging of resectable colon cancer: results of a multicenter study.
Annals of surgery 2004;240(4):624-8; discussion 628-30.
2004: Carol J Swallow; Emily A Partridge; Jennifer C Macmillan; Tania Tajirian; Gianni M DiGuglielmo; Kazy Hay; Melanie Szweras; Willi Jahnen-Dechent; Jeffrey L Wrana; Mark Redston; Steven Gallinger; James W Dennis
alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
Cancer research 2004;64(18):6402-9.
2004: Andrew J Aguirre; Cameron Brennan; Gerald Bailey; Raktim Sinha; Bin Feng; Christopher Leo; Yunyu Zhang; Jean Zhang; Joseph D Gans; Nabeel Bardeesy; Craig Cauwels; Carlos Cordon-Cardo; Mark Redston; Ronald A DePinho; Lynda Chin
High-resolution characterization of the pancreatic adenocarcinoma genome.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(24):9067-72.
2004: Ian D Bookman; Mark Redston; Gordon R Greenberg
Successful treatment of cap polyposis with infliximab.
Gastroenterology 2004;126(7):1868-71.
2004: Matthew H Kulke; Robert D Odze; James D Mueller; Helen Wang; Mark Redston; Monica M Bertagnolli
Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
The Journal of thoracic and cardiovascular surgery 2004;127(6):1579-86.
2004: Riad Haddad; John B Vincent; Robert Gryfe; Hyeja Kim; Joseph Wen; Mark Redston; Stephen W Scherer; Steven Gallinger
Chromosome 7q31 allelic imbalance and somatic mutations of RAY1/ST7 gene in colorectal cancer.
Cancer letters 2004;203(1):87-90.
2003: Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James W Horner; Mark Redston; Ronald A DePinho
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.
Genes & development 2003;17(24):3112-26.
2003: Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
The New England journal of medicine 2003;349(3):247-57.
2003: Christine Brezden-Masley; Melyssa Aronson; Bharati Bapat; Aaron Pollett; Robert Gryfe; Mark Redston; Steven Gallinger
Hereditary nonpolyposis colorectal cancer--molecular basis.
Surgery 2003;134(1):29-33.
2003: Sean P Cleary; William Zhang; Nando Di Nicola; Melyssa Aronson; Jennifer Aube; Amanda Steinman; Riad Haddad; Mark Redston; Steven Gallinger; Steven A Narod; Robert Gryfe
Heterozygosity for the BLM(Ash) mutation and cancer risk.
Cancer research 2003;63(8):1769-71.
2003: Mark Redston
Assembling a tumor progression model.
Methods in molecular biology (Clifton, N.J.) 2003;223():383-401.
2002: Masoom A Haider; Marianne M Amitai; Daniel C Rappaport; Martin E O'Malley; Anthony E Hanbidge; Mark Redston; Gina A Lockwood; Steven Gallinger
Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better?
Radiology 2002;225(1):137-42.
2002: Patricia L Brubaker; Daniel J Drucker; Sylvia Asa; Carol J Swallow; Mark Redston; Gordon R Greenberg
Prolonged gastrointestinal transit in a patient with a glucagon-like peptide (GLP)-1- and -2-producing neuroendocrine tumor.
The Journal of clinical endocrinology and metabolism 2002;87(7):3078-83.
2002: Jane Park; Doron Betel; Robert Gryfe; Katerina Michalickova; Nando Di Nicola; Steven Gallinger; Christopher W V Hogue; Mark Redston
Mutation profiling of mismatch repair-deficient colorectal cncers using an in silico genome scan to identify coding microsatellites.
Cancer research 2002;62(5):1284-8.
2002: Noralane M Lindor; Lawrence J Burgart; Olga Leontovich; Richard M Goldberg; Julie M Cunningham; Daniel J Sargent; Catherine Walsh-Vockley; Gloria M Petersen; Michael D Walsh; Barbara A Leggett; Joanne P Young; Melissa A Barker; Jeremy R Jass; John Hopper; Steven Gallinger; Bharati Bapat; Mark Redston; Stephen N Thibodeau
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):1043-8.
2001: Geeta Lal; C Ash; Kazy Hay; Mark Redston; Elizabeth Kwong; B Hancock; T Mak; Stacia Kargman; Jilly F Evans; Steven Gallinger
Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Cancer research 2001;61(16):6131-6.
2001: MW Thompson-Fawcett; Victoria A Marcus; Mark Redston; Zane Cohen; Robin S McLeod
Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis.
Gastroenterology 2001;121(2):275-81.
2001: Susan J Done; Sasha Eskandarian; S Bull; Mark Redston; Irene L Andrulis
p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.
Journal of the National Cancer Institute 2001;93(9):700-4.
2001: MW Thompson-Fawcett; Victoria A Marcus; Mark Redston; Zane Cohen; Robin S McLeod
Adenomatous polyps develop commonly in the ileal pouch of patients with familial adenomatous polyposis.
Diseases of the colon and rectum 2001;44(3):347-53.
2001: Mark Redston
Carcinogenesis in the GI tract: from morphology to genetics and back again.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(3):236-45.
2000: Takehiko Sasaki; Junko Irie-Sasaki; Y Horie; Kurt Bachmaier; Jimmie E Fata; M Li; Akira Suzuki; Denis Bouchard; Alexandra Ho; Mark Redston; Steven Gallinger; Rama Khokha; Tak W Mak; Phillip T Hawkins; Len Stephens; Stephen W Scherer; May Tsao; Josef M Penninger
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma.
Nature 2000;406(6798):897-902.
2000: Robb E Wilentz; Michael Goggins; Mark Redston; Victoria A Marcus; N Volkan Adsay; Taylor A Sohn; Shrihari S. Kadkol; Charles J Yeo; Michael A Choti; Marianna Zahurak; K Johnson; M Tascilar; G Johan A Offerhaus; Ralph Hruban; Scott E Kern
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity.
The American journal of pathology 2000;156(5):1641-51.
2000: Geeta Lal; Lieqi Liu; David Hogg; Norman Lassam; Mark Redston; Steven Gallinger
Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
Genes, chromosomes & cancer 2000;27(4):358-61.
2000: Geeta Lal; Geoffrey Liu; Beverly Schmocker; P Kaurah; Hilmi Ozcelik; Steven A Narod; Mark Redston; Steven Gallinger
Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Cancer research 2000;60(2):409-16.
2000: Robert Gryfe; H Kim; ET Hsieh; Melyssa Aronson; Eric Holowaty; S B Bull; Mark Redston; Steven Gallinger
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.
The New England journal of medicine 2000;342(2):69-77.
1999: Ziqiang Yuan; Nora Wong; William D Foulkes; L Alpert; F Manganaro; Corinne Andreutti-Zaugg; Richard D Iggo; K Anthony; ET Hsieh; Mark Redston; Leonard Pinsky; Mark Trifiro; Philip H Gordon; Dana Lasko
A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening.
Journal of medical genetics 1999;36(10):790-3.
1999: Victoria A Marcus; Lisa Madlensky; Robert Gryfe; H Kim; K So; Anna Millar; Larissa K Temple; ET Hsieh; T Hiruki; Steven A Narod; Bharati Bapat; Steven Gallinger; Mark Redston
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
The American journal of surgical pathology 1999;23(10):1248-55.
1999: L Mirabelli-Primdahl; Robert Gryfe; H Kim; Anna Millar; C Luceri; Darlene Dale; Eric Holowaty; Bharati Bapat; Steven Gallinger; Mark Redston
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.
Cancer research 1999;59(14):3346-51.
1999: A L Millar; T Pal; Lisa Madlensky; C Sherman; Larissa K Temple; A Mitri; H Cheng; Victoria A Marcus; Steven Gallinger; Mark Redston; Bharati Bapat; Steven A Narod
Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium.
Human molecular genetics 1999;8(5):823-9.
1999: Bharati Bapat; Lisa Madlensky; Larissa K Temple; T Hiruki; Mark Redston; D L Baron; L Xia; Victoria A Marcus; claudio soravia; A Mitri; W Shen; Robert Gryfe; Terri Berk; B N Chodirker; Zane Cohen; Steven Gallinger
Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
Human genetics 1999;104(2):167-76.
1999: Robert Gryfe; Nando Di Nicola; Geeta Lal; Steven Gallinger; Mark Redston
Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.
American journal of human genetics 1999;64(2):378-84.
1998: R C Peralta; AG Casson; R N Wang; S Keshavjee; Mark Redston; Bharati Bapat
Distinct regions of frequent loss of heterozygosity of chromosome 5p and 5q in human esophageal cancer.
International journal of cancer. Journal international du cancer 1998;78(5):600-5.
1998: Robert Gryfe; Nando Di Nicola; Steven Gallinger; Mark Redston
Somatic instability of the APC I1307K allele in colorectal neoplasia.
Cancer research 1998;58(18):4040-3.
1998: Mark Redston; Katherine L Nathanson; Ziqiang Yuan; Susan L Neuhausen; Jaya M Satagopan; Nora Wong; D Yang; D Nafa; JL Abrahamson; Hilmi Ozcelik; Danielle Antin-Ozerkis; Irene L Andrulis; M Daly; Leonard Pinsky; Deborah Schrag; S Gallinger; M Kaback; Mary-Claire King; T Woodage; Lawrence C Brody; A Godwin; Ellen Warner; Barbara Weber; William D Foulkes; Kenneth Offit
The APCI1307K allele and breast cancer risk.
Nature genetics 1998;20(1):13-4.
1998: Minh D To; Susan J Done; Mark Redston; Irene L Andrulis
Analysis of mRNA from microdissected frozen tissue sections without RNA isolation.
The American journal of pathology 1998;153(1):47-51.
1998: Susan J Done; Nona C R Arneson; H Ozçelik; Mark Redston; Irene L Andrulis
p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
Cancer research 1998;58(4):785-9.
1997: Robert Gryfe; Carol J Swallow; Bharati Bapat; Mark Redston; Steven Gallinger; Jean Couture
Molecular biology of colorectal cancer.
Current problems in cancer 1997;21(5):233-300.
1997: H Ozçelik; Beverly Schmocker; Nando Di Nicola; X H Shi; B Langer; M Moore; B R Taylor; Steven A Narod; G Darlington; Irene L Andrulis; Steven Gallinger; Mark Redston
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients.
Nature genetics 1997;16(1):17-8.
1997: Lisa Madlensky; Bharati Bapat; Mark Redston; R Pearl; Steven Gallinger; Zane Cohen
Using genetic information to make surgical decisions: report of a case of a 13-year-old boy with colon cancer.
Diseases of the colon and rectum 1997;40(2):240-3.
1996: Armin Reitmair; Mark Redston; J C Cai; T C Chuang; Matthew Bjerknes; Hazel Cheng; K Hay; Steven Gallinger; Bharati Bapat; Tak W Mak
Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.
Cancer research 1996;56(16):3842-9.
1996: Armin Reitmair; J C Cai; Matthew Bjerknes; Mark Redston; Hazel Cheng; M T Pind; K Hay; A Mitri; Bharati Bapat; Tak W Mak; Steven Gallinger
MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
Cancer research 1996;56(13):2922-6.
1995: Armin Reitmair; R Schmits; A Ewel; Bharati Bapat; Mark Redston; A Mitri; P Waterhouse; Hans-Willi Mittrücker; Andrew Wakeham; B Liu
MSH2 deficient mice are viable and susceptible to lymphoid tumours.
Nature genetics 1995;11(1):64-70.
1995: Lisa Madlensky; Terri Berk; Bharati Bapat; Robin S McLeod; Jean Couture; D Baron; T Hiruki; Mark Redston; Zane Cohen; Steven Gallinger
A preventive registry for hereditary nonpolyposis colorectal cancer.
The Canadian journal of oncology 1995;5(2):355-60.